Introduction
Humans are exposed to a variety of chemicals, pathogens, or conditions that produce chronic liver injury, including alcohol, hepatitis viruses, autoimmune diseases, and genetic disorders. The liver responds to injury by producing soluble mediators, such as growth factors, that facilitate liver repair (Fausto, 2000) . This process is essential for restoration of liver homeostasis following acute injury. During chronic injury, however, persistent activation of these pathways promotes pathological processes, including fibrosis and cancer (Friedman, 2008) .
Macrophages play an integral role in the development of liver fibrosis. Studies have shown that depletion of macrophages slows the progression of fibrosis in animal models (Rivera et al., 2001; Duffield et al., 2005) . The mechanism by which macrophages promote fibrosis is not completely understood, although, studies have shown that these cells express key JPET #189340 6 study suggested that hypoxia may be a key driving force for the production of profibrotic mediators by macrophages during fibrosis. These studies further demonstrated that upregulation of PDGF-B and MCP-1 in hypoxic Kupffer cells required the transcription factor hypoxia-inducible factor-1α (HIF-1α) (Copple et al., 2010) .
HIFs are a group of transcription factors activated in hypoxic cells (Semenza and Wang, 1992; Gaber et al., 2005; Coleman and Ratcliffe, 2007) . The functional HIF transcription factor is composed of an α subunit, either HIF-1α or HIF-2α, and a β subunit, HIF-1β. When cells become hypoxic, HIF-α protein subunits become stabilized and translocate to the nucleus where they heterodimerize with HIF-1β and regulate expression of genes that allow cells to adapt to a hypoxic environment (Cash et al., 2007) . Our recent studies demonstrated that HIF-1α is activated in macrophages in the livers of bile duct-ligated (BDL) mice, an animal model of peribiliary fibrosis (Moon et al., 2009) . Whether activation of HIF-1α in hepatic macrophages in vivo is a key event in the development of liver fibrosis, however, is not known. Accordingly, in the present study, the hypothesis was tested that HIF-1α activation in macrophages is critical for upregulation of profibrotic mediators and the development of liver fibrosis in vivo.
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PCR kit (Applied Biosystems). Real-time PCR was used to quantify mRNA levels on an Applied Biosystems Prism 7300 Real-time PCR Instrument (Applied Biosystems) using the SYBR green DNA PCR kit (Applied Biosystems) as described (Kim et al., 2006) . Primer sequences for realtime PCR are shown in Table 1 .
Kupffer Cell Isolation: Kupffer cells were isolated from mice and exposed to hypoxia as described by us previously (Copple et al., 2010) .
Western Blot Analysis: Nuclear extracts were isolated from Kupffer cells as described previously (Copple et al., 2010) . For western blot analysis, aliquots (15 µg) of nuclear extracts were subjected to 10% SDS-polyacrylamide gel electrophoresis, and proteins were transferred to Immobilon polyvinylidene difluoride transfer membranes (Millipore Corporation, Bedford, MA).
The membranes were then probed with rabbit polyclonal anti-HIF-1α antibody (NB100-449, Novus Biologicals, Littleton, CO) diluted 1:1000 or mouse monoclonal anti-HIF-1β (Millipore) diluted 1:1000 followed by incubation with goat anti-rabbit antibody conjugated to horseradish peroxidase (Santa Cruz Biotechnology) for HIF-1α or goat anti-mouse antibody conjugated to horseradish peroxidase (Santa Cruz Biotechnology) for HIF-1β.
For TGF-β1 western blot, aliquots of liver extract (50 μg) were separated on a 10% SDSpolyacrylamide gel under non-denaturing conditions. TGF-β1 was detected using a monoclonal anti-TGF-β1 antibody (clone 9016; R&D Systems, Minneapolis, MN).
Quantification of Type I Collagen, Cre Recombinase, Macrophages, and Neutrophils in the Liver: Type I collagen in the liver was detected using immunohistochemistry and quantified morphometrically by analyzing the area of immunohistochemical staining of type I collagen as described by us previously (Kim et al., 2006; Moon et al., 2009 ). An increase in the area of type I collagen staining in the liver is an indicator of fibrosis. Fluorescent staining in sections of liver was visualized on an Olympus BX41 microscope (Olympus, Lake Success, NY). For morphometric analysis of the total area of type I collagen in a liver section, digital images of 10, randomly chosen, low power (100X magnification) fields per tissue section were captured using an Olympus DP70 camera. Samples were coded such that the evaluator was not aware of the treatment, and the same exposure time was used for all captured images. Scion Image software (Scion Corporation, Frederick, MD) was then used to quantify the total area of type I collagen (number of positive pixels) using methods described in detail previously (Copple et al., 2002) . The staining is expressed as a fraction of the total area. The 10 random fields analyzed for each liver section were averaged and counted as a replicate, i.e., each replicate represents a different mouse.
Neutrophils were detected in sections of liver and quantified as described previously (Kim et al., 2006) .
For quantification of macrophages in the liver, sections of frozen liver were fixed in 4% formalin and then incubated with rat anti-mouse CD68 and rat anti-mouse F4/80 antibodies diluted 1:100 (AbD Serotec, Raleigh, NC). The sections were then incubated with goat anti-rat antibody conjugated with Alexa 488. The area of immunohistochemical staining was then quantified in sections of liver as described above for collagen quantification. 
Results

HIF-1β Deletion in Myeloid Cells does not affect Liver Injury or Hepatic
Inflammation after BDL. To determine whether HIF-1β in myeloid cells is critical for the development of liver fibrosis, HIF-1β fl/fl mice were crossed with LysMCre mice. To confirm that HIF-1β was deleted in hepatic macrophages (i.e., Kupffer cells), these cells were isolated from HIF-1βLysMCre -and HIF-1βLysMCre + mice, and HIF-1β was detected by western blot. HIF-1β was detected in Kupffer cells from HIF-1βLysMCre -mice but not in Kupffer cells from HIF1βLysMCre + mice ( Figure 1A ). Next, to confirm that Cre recombinase was only expressed in macrophages in the liver, Cre recombinase was detected by immunohistochemistry in sections of liver from HIF-1βLysMCre + mice subjected to BDL (red staining, Figure 1B ). Macrophages were then identified in the same section of liver by immunohistochemistry (green staining, Figure 1C ). When Cre recombinase immunostaining and macrophage immunostaining were overlaid, Cre recombinase was only detected in hepatic macrophages ( Figure 1D ).
Next, HIF-1βLysMCre -and HIF-1βLysMCre + mice were subjected to BDL and liver injury and inflammation were assessed 10 days after surgery. ALT, bilirubin, ALP, and bile acids in serum were increased to a similar extent in HIF-1βLysMCre -mice and HIF-1βLysMCre + mice at 10 days after BDL (Table 2 ). In addition, the extent of necrosis was similar in these mice after BDL (Figures 2).
To evaluate the extent of hepatic inflammation after BDL, macrophages and neutrophils were detected in sections of liver by immunohistochemistry. In addition, levels of proinflammatory mediators were quantified by real-time PCR. Macrophage and neutrophil numbers were increased to a similar extent in the livers of HIF-1βLysMCre -and HIF1βLysMCre + mice after BDL ( Figure 3 ). In addition, upregulation of the chemokines, keratinocyte-derived chemotactic factor (KC) and macrophage inflammatory protein-2 (MIP-2), and upregulation of the cytokine tumor necrosis factor-α (TNF-α) were unaffected by deficiency of HIF-1β in myeloid cells (Table 3) .
HIF-1β Deletion in Myeloid Cells
Reduces Liver Fibrosis after BDL. Next, we evaluated biomarkers of liver fibrosis to test the hypothesis that HIF activation in myeloid cells is required for the development of liver fibrosis after BDL. α-smooth muscle actin mRNA levels were increased to a greater extent in the livers of HIF-1βLysMCre -mice after BDL when compared to bile duct-ligated HIF-1βLysMCre + mice ( Figure 4A ). Type I collagen mRNA levels were increased in the livers of HIF-1βLysMCre -mice after BDL ( Figure 4B ). Type I collagen mRNA levels were significantly lower in HIF-1βLysMCre + mice after BDL ( Figure 4B ).
Extensive deposition of type I collagen protein was observed in periportal regions of liver from HIF-1βLysMCre -mice after BDL ( Figure 4C ). Lower levels of type I collagen were observed in bile duct-ligated HIF-1βLysMCre + mice ( Figure 4D ). A significant reduction in hepatic type I collagen protein in these mice was confirmed by quantification of the area of immunohistochemical staining of type I collagen in sections of liver ( Figure 4E ). These data demonstrate that HIF signaling in myeloid cells is important for the development of liver fibrosis after BDL.
HIF-1β in Myeloid Cells is required for Upregulation of PDGF-B after BDL. Next we
determined whether HIF-1β deficiency affected upregulation of mediators that are important for development of fibrosis, such as plasminogen activator inhibitor-1 (PAI-1), fibroblast growth factor-2 (FGF-2), platelet-derived growth factor-B (PDGF-B), monocyte chemotactic protein-1 (MCP-1), and transforming growth factor-β1 (TGF-β1). In addition, we determined the impact of
HIF deficiency in myeloid cells on levels of proangiogenic mediators, including vascular
This article has not been copyedited and formatted. The final version may differ from this version. endothelial growth factor-A (VEGF-A), angiopoietin-1 (Ang-1), and Ang-2. PAI-1, FGF-2, PDGF-B, and MCP-1 mRNA levels were increased in HIF-1βLysMCre -mice after BDL (Table   4) . PDGF-B and MCP-1 mRNA levels were significantly lower in HIF-1βLysMCre + after BDL when compared to HIF-1βLysMCre -mice (Table 4 ). In contrast, mRNA levels of VEGF-A, Ang-1, and Ang-2 were not significantly increased in the livers of either HIF-1βLysMCre -or HIF-1βLysMCre + after BDL (Table 4) . To confirm this, we evaluated VEGF-A protein levels by western blot and immunohistochemistry. Consistent with VEGF-A mRNA levels, VEGF-A protein was not increased in the liver by 10 days after BDL (data not shown).
Levels of latent TGF-β1 protein (75 kD) and active TGF-β1 protein (25 kD) were increased to a similar extent in the livers of HIF-1βLysMCre -and HIF-1βLysMCre + mice after BDL ( Figure 5 ). Consistent with this, the ratio of active TGF-β1 to latent TGF-β1 was not different between HIF-1βLysMCre -and HIF-1βLysMCre + mice after BDL (HIF-1βLysMCre -:
0.44 +/-0.07 vs. HIF-1βLysMCre +: 0.53 +/-0.05).
Since myeloid cell-specific HIF-1β deficiency largely prevented the increase in PDGF-B and MCP-1 mRNAs in the liver, we next evaluated whether PDGF-B and MCP-1 protein levels were increased in a HIF-1β-dependent manner. Immunohistochemistry was used to detect PDGF-B protein in hepatic macrophages. PDGF-B protein was not detected in livers from
sham-operated mice (data not shown). PDGF-B protein levels were increased in the livers of HIF-1βLysMCre -mice after BDL ( Figure 6B , green staining). Furthermore, PDGF-B protein (green staining) co-localized with hepatic macrophages (red staining) in these mice ( Figure 6C ).
In contrast, PDGF-B protein was not detected in hepatic macrophages in HIF-1βLysMCre + mice after BDL ( Figures 6D-6F ). Next, serum concentrations of MCP-1 protein were quantified.
This article has not been copyedited and formatted. The final version may differ from this version. In contrast to MCP-1 mRNA levels (Table 4) HIF-1α protein levels were substantially lower in hypoxic Kupffer cells isolated from HIF1αLysMCre + mice ( Figure 7A ).
ALT activity was increased to a similar extent in HIF-1αLysMCre -and HIF-1αLysMCre + after BDL ( Figure 7B ). In addition, pathological changes that occurred in the liver were similar ( Figures 7C and 7D ). mRNA levels of α-smooth muscle actin, type I collagen, and PDGF-B
were increased in HIF-1αLysMCre-mice after BDL (Figure 8 ). mRNA levels of all of these genes were significantly lower in bile duct-ligated HIF-1αLysMCre + mice (Figure 8 ).
Activation of HIF-1α in Macrophages, Hepatocytes, and Fibroblasts in Livers of
Patients with Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
Immunohistochemistry was used to detect HIF-1α in macrophages and fibroblasts in livers from three patients with PBC, 3 patients with PSC, and 3 normal human livers. Nuclear accumulation of HIF-1α was observed in macrophages in the liver of a patient with PBC ( Figure 9A ). In addition, nuclear HIF-1α was observed in hepatocytes adjacent to HIF-1α-positive macrophages ( Figure 9A ). HIF-1α was detected in macrophages in livers from all three patients with PBC. Similarly, nuclear HIF-1α was observed in macrophages in all livers from patients with PSC ( Figure 9C ). In contrast, HIF-1α protein was not detected in the nuclei of macrophages in normal human livers ( Figure 9E ). We also observed nuclear HIF-1α protein in cells within fibrotic regions of liver from patients with PBC and PSC; therefore, we determined whether fibroblasts, identified by α-SMA immunostaining, were positive for HIF-1α. As shown in Figure 9G , HIF-1α protein was detected in the nuclei of α-SMA-positive cells in all livers from patients with PBC and PSC. In addition, HIF-1α protein was detected in the nuclei of hepatocytes adjacent to regions of bridging fibrosis ( Figure 9G ). 
Discussion
Our results demonstrate that HIF-1β and HIF-1α in myeloid cells contribute to the development of liver fibrosis after BDL. In LysMCre mice, Cre recombinase is expressed in macrophages and neutrophils (Clausen et al., 1999) . Accordingly, it is possible that HIF-1β and HIF-1α deletion in macrophages and/or neutrophils was responsible for the reduction of fibrosis observed in our studies. A recent study showed, however, that neutrophil depletion does not affect development of liver fibrosis after BDL (Saito et al., 2003) . Accordingly, it is unlikely that HIF activation in neutrophils contributes to the development of fibrosis after BDL. Therefore, our results indicate HIF-1β and HIF-1α in macrophages is important for liver fibrosis.
The mechanism by which activation of HIFs in macrophages promoted fibrosis may be in part due to HIF-dependent production of PDGF-B by hepatic macrophages during chronic injury. An interesting observation from these studies is that although deficiency of either HIF-1α
PDGF-B is a potent mitogen and chemotaxin for hepatic stellate cells (Friedman and
or HIF-1β in myeloid cells reduced liver fibrosis after BDL, it did not affect hepatocyte injury.
This suggests that liver fibrosis after BDL is not dependent upon hepatocyte injury. Consistent with this observation, we demonstrated previously that early growth response factor-1 knockout mice had reduced liver injury and neutrophil accumulation after BDL when compared to wildtype mice, but had similar levels of fibrosis (Kim et al., 2006) . Similarly, Fickert and colleagues demonstrated that FXR knockout mice have reduced liver fibrosis after BDL but have similar levels of liver injury when compared to wild-type mice (Fickert et al., 2009) . Collectively, these studies indicate that hepatocyte injury after BDL is not an important stimulus for hepatic fibrosis.
It remains possible, however, that HIFs may contribute to the development of liver injury at
This article has not been copyedited and formatted. The final version may differ from this version. Studies indicate that angiogenesis is important for the development of hepatic fibrosis (Rosmorduc et al., 1999; Corpechot et al., 2002; Taura et al., 2008) . Furthermore, a key function of HIFs is to regulate production of pro-angiogenic mediators (Forsythe et al., 1996; Kelly et al., 2003; Yamakawa et al., 2003) . Surprisingly, however, although HIF-1α was activated in the liver after BDL, levels of pro-angiogenic mediators, such as VEGF-A and angiopoietins, remained unchanged. We reported previously that hypoxia increases expression of VEGF-A in primary mouse hepatocytes, Kupffer cells, and hepatic stellate cells in a HIF-1α-dependent manner (Copple et al., 2009; Copple et al., 2010; Copple et al., 2011) , demonstrating that HIF-1α regulates production of these mediators in these cells types. One possible explanation for the lack of induction of pro-angiogenic mediators may be that they are transiently produced and the time-point we chose did not coincide with upregulation of VEGF-A and angiopoietins. In addition, it is possible that upregulation of VEGF-A occurs at a later timepoint in this model. Consistent with this, it was shown previously that upregulation of VEGF in the livers of rats after BDL required several weeks (Rosmorduc et al., 1999) .
In addition to detecting nuclear HIF-1α protein in macrophages in the livers of patients with PBC and PSC, we also detected nuclear HIF-1α protein in α-SMA positive cells (Figure 9 ).
We recently demonstrated that exposure of primary mouse hepatic stellate cells to hypoxia increased expression of a number of genes involved in the genesis of liver fibrosis, including the chemokine receptors Ccr1 and Ccr5, prolyl-4-hydroxylase α1, prolyl-4-hydroxylase α2, and the Many of these were increased in hepatic stellate cells in a HIF-dependent manner (Copple et al., 2011) . Accordingly, it is possible that in addition to macrophages, activation of HIF-1α in hepatic stellate cells may be important for the development of liver fibrosis.
Collectively, these studies demonstrate that HIF-1α and HIF-1β are important regulators of profibrotic mediator production by macrophages during the development of liver fibrosis in cholestatic mice. Furthermore, these studies indicate that this mechanism may be important for fibrosis development in humans as HIF-1α was activated in macrophages in the livers of patients with PBC and PSC. Accordingly, these studies suggest that therapeutic targeting of HIF-1α may be effective at preventing the progression of liver fibrosis in patients with cholestatic liver disease and potentially in patients with liver fibrosis produced by other hepatic insults.
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